Cargando…

Poor prognosis of nucleophosmin overexpression in solid tumors: a meta-analysis

BACKGROUND: Nucleophosmin is a non-ribosomal nucleolar phosphoprotein that is found primarily in the nucleolus region of cell nucleus, plays multiple important roles in tumor processes. Accumulated previous studies have reported a potential value of NPM acted as a biomarker for prognosis in various...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Siying, He, Hairong, Wang, Yan, Liu, Leichao, Liu, Yang, You, Haisheng, Dong, Yalin, Lyu, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6102940/ https://www.ncbi.nlm.nih.gov/pubmed/30126359 http://dx.doi.org/10.1186/s12885-018-4718-6

Ejemplares similares

SE translation mRNA overexpression: a potential prognostic predictor in breast cancer
por: Du, Qian, et al.
Publicado: (2019)

Poor prognosis and SATB1 overexpression in solid tumors: a meta-analysis
por: Wang, Shengjie, et al.
Publicado: (2018)

Prognostic factors and survival outcomes according to tumor subtype in patients with breast cancer lung metastases
por: Chen, Siying, et al.
Publicado: (2019)

Poor prognosis of hexokinase 2 overexpression in solid tumors of digestive system: a meta-analysis
por: Wu, Jiayuan, et al.
Publicado: (2017)

CDC20 overexpression leads to poor prognosis in solid tumors: A system review and meta-analysis
por: Wang, Shengjie, et al.
Publicado: (2018)

Development and Validation of a Nomogram for Predicting Survival in Male Patients With Breast Cancer
por: Chen, Siying, et al.
Publicado: (2019)

NEDD9 overexpression predicts poor prognosis in solid cancers: a meta-analysis
por: Gu, Yang, et al.
Publicado: (2019)

APE1 overexpression is associated with poor survival in patients with solid tumors: a meta-analysis
por: Yuan, Chun-Ling, et al.
Publicado: (2017)

Loss of heterozygosity on chromosome 16q increases relapse risk in Wilms’ tumor: a meta-analysis
por: Pan, Zhenyu, et al.
Publicado: (2017)

PSMB5 overexpression is correlated with tumor proliferation and poor prognosis in hepatocellular carcinoma
por: Liu, Jun, et al.
Publicado: (2022)

Overexpression of CENPF correlates with poor prognosis and tumor bone metastasis in breast cancer
por: Sun, Jingbo, et al.
Publicado: (2019)

Overexpression of prostate tumor overexpressed 1 correlates with tumor progression and predicts poor prognosis in breast cancer
por: Lei, Fangyong, et al.
Publicado: (2014)

Pyruvate kinase M2 overexpression and poor prognosis in solid tumors of digestive system: evidence from 16 cohort studies
por: Wu, Jiayuan, et al.
Publicado: (2016)

High expression of LEF1 correlates with poor prognosis in solid tumors, but not blood tumors: a meta-analysis
por: Yang, Xiaoqi, et al.
Publicado: (2020)

The role of SOX2 overexpression in prognosis of patients with solid tumors: A meta-analysis and system review
por: Wang, Shengjie, et al.
Publicado: (2020)

NUCLEOPHOSMIN MUTATION IS DOUBLE TROUBLE
por: Robinson, Richard
Publicado: (2008)

Nucleophosmin in Its Interaction with Ligands
por: Cela, Ilaria, et al.
Publicado: (2020)

Overexpression of CENPF is associated with progression and poor prognosis of lung adenocarcinoma
por: Li, Mei-Xiang, et al.
Publicado: (2021)

Playing both sides: nucleophosmin between tumor suppression and oncogenesis
por: Di Fiore, Pier Paolo
Publicado: (2008)

CDCA5 overexpression is an Indicator of poor prognosis in patients with hepatocellular carcinoma (HCC)
por: Tian, Yunhong, et al.
Publicado: (2018)

A prognostic model for elderly patients with squamous non-small cell lung cancer: a population-based study
por: Chen, Siying, et al.
Publicado: (2020)

Overexpression of PLOD3 promotes tumor progression and poor prognosis in gliomas
por: Tsai, Chia-Kuang, et al.
Publicado: (2018)

Overexpression of prothymosin-α in glioma is associated with tumor aggressiveness and poor prognosis
por: Kumar, Anurag, et al.
Publicado: (2022)

Overexpression of CDCA8 Predicts Poor Prognosis and Promotes Tumor Cell Growth in Prostate Cancer
por: Wan, Shun, et al.
Publicado: (2022)

Overexpression of EFEMP1 Correlates with Tumor Progression and Poor Prognosis in Human Ovarian Carcinoma
por: Chen, Jie, et al.
Publicado: (2013)

Overexpression of RBM34 Promotes Tumor Progression and Correlates with Poor Prognosis of Hepatocellular Carcinoma
por: Wang, Wei, et al.
Publicado: (2023)

Low NDRG2 expression predicts poor prognosis in solid tumors: A meta-analysis of cohort study
por: Gu, Aiqin, et al.
Publicado: (2020)

PB1841: NUCLEOLIN INTERACTS WITH NUCLEOPHOSMIN AS A PREDICTOR OF PROGNOSIS IN ACUTE MYELOBLASTIC LEUKEMIA
por: Pereira, Marta, et al.
Publicado: (2023)

RAB10 overexpression promotes tumor growth and indicates poor prognosis of hepatocellular carcinoma
por: Wang, Wei, et al.
Publicado: (2017)

Cryptochrome 1 Overexpression Correlates with Tumor Progression and Poor Prognosis in Patients with Colorectal Cancer
por: Yu, Hongyan, et al.
Publicado: (2013)

Overexpression of CDCA8 promotes the malignant progression of cutaneous melanoma and leads to poor prognosis
por: Ci, Chao, et al.
Publicado: (2019)

Structural investigation of nucleophosmin interaction with the tumor suppressor Fbw7γ
por: Di Matteo, A, et al.
Publicado: (2017)

Overexpression of CLEC3A promotes tumor progression and poor prognosis in breast invasive ductal cancer
por: Ni, Jun, et al.
Publicado: (2018)

Overexpression of CD55 correlates with tumor progression and poor prognosis in gastric stromal tumors
por: Yin, Xiaonan, et al.
Publicado: (2019)

Eg5 Overexpression Is Predictive of Poor Prognosis in Hepatocellular Carcinoma Patients
por: Liu, Can, et al.
Publicado: (2017)

Overexpression of CIP2A is associated with poor prognosis in multiple myeloma
por: Liu, Xuewen, et al.
Publicado: (2017)

Overexpression of DJ-1 correlates with aggressive clinicopathological characteristics and poor prognosis in malignant tumors: a meta-analysis
por: Wang, Qingting, et al.
Publicado: (2018)

Humoral autoimmune response to nucleophosmin in the immunodiagnosis of hepatocellular carcinoma
por: LIU, MEI, et al.
Publicado: (2015)

Overexpression of glypican-3 is a predictor of poor prognosis in hepatocellular carcinoma: An updated meta-analysis
por: Zhang, Jian, et al.
Publicado: (2018)

Cyclin D1 overexpression is associated with poor prognosis in oropharyngeal cancer
por: Lin, Rui Jun, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_3aj18boucpi1kpoihfh7819gdt